Muto, V.; Benigni, F.; Magliocca, V.; Borghi, R.; Flex, E.; Pallottini, V.; Rosa, A.; Compagnucci, C.; Tartaglia, M.
CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes. Int. J. Mol. Sci. 2023, 24, 7988.
https://doi.org/10.3390/ijms24097988
AMA Style
Muto V, Benigni F, Magliocca V, Borghi R, Flex E, Pallottini V, Rosa A, Compagnucci C, Tartaglia M.
CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes. International Journal of Molecular Sciences. 2023; 24(9):7988.
https://doi.org/10.3390/ijms24097988
Chicago/Turabian Style
Muto, Valentina, Federica Benigni, Valentina Magliocca, Rossella Borghi, Elisabetta Flex, Valentina Pallottini, Alessandro Rosa, Claudia Compagnucci, and Marco Tartaglia.
2023. "CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes" International Journal of Molecular Sciences 24, no. 9: 7988.
https://doi.org/10.3390/ijms24097988
APA Style
Muto, V., Benigni, F., Magliocca, V., Borghi, R., Flex, E., Pallottini, V., Rosa, A., Compagnucci, C., & Tartaglia, M.
(2023). CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes. International Journal of Molecular Sciences, 24(9), 7988.
https://doi.org/10.3390/ijms24097988
